Arrow Alexander K. 4
4 · Protagenic Therapeutics, Inc.\new · Filed Oct 18, 2017
Insider Transaction Report
Form 4
Arrow Alexander K.
Chief Financial Officer
Transactions
- Award
Non-Qualified Stock Options (Right to Buy)
2017-10-16+75,000→ 75,000 totalExercise: $1.75Exp: 2027-10-16→ Protagenic Therapeutics, Inc. Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Vesting in equal installments over 36 months, full vesting upon change of control